Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

(2011) Carlos O. Mendivil et al.   CIRCULATION

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial

(2011) L-S Tam et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors

(2010) Tracey E. Toms et al.   Current Vascular Pharmacology

Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis

(2010) Jean-Frédéric Boyer et al.   JOINT BONE SPINE

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity

(2010) N Vuilleumier et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

(2009) E Choy et al.   ANNALS OF THE RHEUMATIC DISEASES

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

(2007) A Gonzalez et al.   ANNALS OF THE RHEUMATIC DISEASES